Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome

Non-alcoholic fatty liver disease (NAFLD) is estimated to affect 24% of the global adult population. NAFLD is a major risk factor for the development of cirrhosis and hepatocellular carcinoma, as well as being...

Source: Clinical Epigenetics - July 18, 2019 Category: Research Authors: Matthew C. Sinton, David C. Hay and Amanda J. Drake Tags: Review Source Type: research